Business Standard

Monday, January 06, 2025 | 01:47 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

HUL, GSK Asia to scrap distribution pact for OTC products by next year

In 2018, HUL had announced that GSK Consumer Healthcare will merge with HUL in an all-stock deal

HUL’s foods and refreshments category grew 5 per cent in Q4, aided by beverages and ice-cream.
Premium

In 2018, HUL had announced that GSK Consumer Healthcare would merge with HUL in an all-stock deal

Sharleen D'Souza Mumbai
Hindustan Unilever (HUL) and GSK Consumer have mutually decided to terminate the distribution agreement of GSK Consumer’s over-the-counter (OTC) products that include  Eno, Crocin, Iodex, Sensodyne by November 2023, HUL said in a stock exchange filing. This agreement ends 1.5 years ahead of the agreed period.

“The company, GSKAPL (GSK Asia) and GSKCPL (GSK Consumer)  have mutually agreed and expressed their intention to terminate the Agreement(s) with effect from 8th November, 2023.

As per the Agreement(s), the one-year notice period for termination shall commence from 9th November, 2022,” HUL said. It added that this shall not have any material

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in